Stay updated on Pembrolizumab for Pediatric Hodgkin Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Pediatric Hodgkin Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Pediatric Hodgkin Lymphoma Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The Plain Language Summary has been removed from the Study Details page, eliminating the lay-friendly overview of the trial’s purpose and design. This shifts the page toward more technical content and may affect how easily non-specialists can understand the study.
    Difference
    0.0%
    Check dated 2026-08-04T09:36:14.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.3 to v3.6.4. This reflects a minor internal update with no visible changes to study content or user-facing features.
    Difference
    0.0%
    Check dated 2026-07-28T05:50:24.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    Revision: v3.6.3 was added and Revision: v3.6.2 was removed. This reflects a minor update to the study record's version metadata.
    Difference
    0.0%
    Check dated 2026-07-06T16:30:10.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.0 to v3.6.2, indicating a minor update to the document's metadata.
    Difference
    0.0%
    Check dated 2026-06-29T09:55:50.000Z thumbnail image
  7. Check
    54 days ago
    Change Detected
    Summary
    The study page now indicates that enrollment has ended by adding 'No longer looking for participants'. The new sections for How to Read a Study Record, Common Questions, and How to Join a Study were added, while the Intervention/Treatment heading formatting was adjusted and the revision version updated from v3.5.5 to v3.6.0.
    Difference
    0.2%
    Check dated 2026-06-15T08:21:34.000Z thumbnail image
  8. Check
    61 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.5.4 to v3.5.5, indicating a minor update to the page metadata or content. It does not alter the study details or eligibility information.
    Difference
    0.0%
    Check dated 2026-06-08T03:56:07.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Pediatric Hodgkin Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Pediatric Hodgkin Lymphoma Clinical Trial page.